)
SC questions hospital drug mark-ups; hospital stocks fall up to 7%
- Apollo Hospitals, Fortis, KIMS and others fell up to 6% in one report and 7% in another
- The court flagged the gap between price-to-retailer and maximum retail prices of essential medicines
- Drug-pricing scrutiny pressures hospital operators Apollo Hospitals, Fortis Healthcare, KIMS and Max Healthcare